These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32447627)

  • 21. Lung cancer screening: Current status and perspective.
    Chassagnon G; Revel MP
    Diagn Interv Imaging; 2016 Oct; 97(10):949-953. PubMed ID: 27527243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for lung cancer with low-dose CT.
    Coche E
    JBR-BTR; 2008; 91(1):1-5. PubMed ID: 18447122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung Cancer Screening.
    Hoffman RM; Sanchez R
    Med Clin North Am; 2017 Jul; 101(4):769-785. PubMed ID: 28577626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of the national lung cancer screening trial: where are we now?
    Chudgar NP; Bucciarelli PR; Jeffries EM; Rizk NP; Park BJ; Adusumilli PS; Jones DR
    Thorac Surg Clin; 2015 May; 25(2):145-53. PubMed ID: 25901558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on Lung Cancer Screening.
    Brownlee AR; Donington JS
    Semin Respir Crit Care Med; 2020 Jun; 41(3):447-452. PubMed ID: 32450597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A practical and adaptive approach to lung cancer screening: a review of international evidence and position on CT lung cancer screening in the Singaporean population by the College of Radiologists Singapore.
    Liew CJY; Leong LCH; Teo LLS; Ong CC; Cheah FK; Tham WP; Salahudeen HMM; Lee CH; Kaw GJL; Tee AKH; Tsou IYY; Tay KH; Quah R; Tan BP; Chou H; Tan D; Poh ACC; Tan AGS
    Singapore Med J; 2019 Nov; 60(11):554-559. PubMed ID: 31781779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening for lung cancer using CT: time for implementation?].
    de Jong PA; Lammers JW
    Ned Tijdschr Geneeskd; 2013; 157(46):A7019. PubMed ID: 24220184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose computed tomography screening for lung cancer: results of the first screening round.
    Horeweg N; Nackaerts K; Oudkerk M; de Koning HJ
    J Comp Eff Res; 2013 Sep; 2(5):433-6. PubMed ID: 24236740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose computed tomographic screening for lung cancer.
    Christensen JD; Chiles C
    Clin Chest Med; 2015 Jun; 36(2):147-60, vii. PubMed ID: 26024597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Economic impact of lung cancer screening in France: A modeling study].
    Gendarme S; Perrot É; Reskot F; Bhoowabul V; Fourre G; Souquet PJ; Milleron B; Couraud S
    Rev Mal Respir; 2017 Sep; 34(7):717-728. PubMed ID: 26585377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.
    Han D; Heuvelmans MA; Vliegenthart R; Rook M; Dorrius MD; Oudkerk M
    J Thorac Imaging; 2019 Jan; 34(1):65-71. PubMed ID: 30325795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
    Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
    Jaine R; Kvizhinadze G; Nair N; Blakely T
    Lung Cancer; 2018 Oct; 124():233-240. PubMed ID: 30268467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospects for population screening and diagnosis of lung cancer.
    Field JK; Oudkerk M; Pedersen JH; Duffy SW
    Lancet; 2013 Aug; 382(9893):732-41. PubMed ID: 23972816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of risk prediction models to lung cancer screening: a review.
    Tammemägi MC
    J Thorac Imaging; 2015 Mar; 30(2):88-100. PubMed ID: 25692785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.